Literature DB >> 20811692

The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk.

Bruno Costa Gomes1, Susana Nunes Silva, Ana Paula Azevedo, Isabel Manita, Octávia Monteiro Gil, Teresa Cruz Ferreira, Edward Limbert, José Rueff, Jorge Francisco Gaspar.   

Abstract

Variations, such as single nucleotide polymorphisms (SNPs) in DNA damage repair genes have been pointed out as possible factors to cancer predisposition. Ionizing radiation (IR) induces DNA double strand breaks (DSBs) and is the main recognized risk factor for thyroid cancer. However, most of the patients do not show chronic contact with IR and the other factors have non-concordant data. Thus, thyroid cancer could be due to gene variations in association with certain exogenous factors. One of the pathways that repair DSBs is DNA non-homologous end-joining (NHEJ) that comprises several polymorphic genes. We intend to study the role of polymorphic variants in XRCC4, LIG4 and Ku80 genes, since there is scarcity of data on the role of these genes in thyroid cancer susceptibility. We carried out a hospital-based case-control study in a Caucasian Portuguese population (109 patients and 217 controls) to estimate the potential role of the XRCC4 (N298S and T134I), LIG4 (T9I) and Ku80 (Ex21-238Gright curved arrow A, Ex21+338Tright curved arrow C, Ex21-352Cright curved arrow A, Ex21+466Aright curved arrow G) polymorphisms in the individual susceptibility for this disease. The results here reported do not associate these polymorphisms with susceptibility for non-familial thyroid cancer. However, when the data were analyzed according to the type of tumour, significant results for Ku80 Ex21-238Gright curved arrow A and Ex21+466Aright curved arrow G were found for papillary tumours (adjusted OR = 2.281; 95% CI =; 1.063-4.894; P=0.034). Taken together these results suggest that some of these variants in NHEJ genes can contribute to thyroid cancer susceptibility. However, further studies with a larger sample size will be needed to support our results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811692

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Prevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population.

Authors:  Ana Paula Azevedo; Susana N Silva; Alice Reichert; Fernando Lima; Esmeraldina Júnior; José Rueff
Journal:  Biomed Rep       Date:  2017-09-05

2.  Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.

Authors:  L A Henríquez-Hernández; A Valenciano; P Foro-Arnalot; M J Álvarez-Cubero; J M Cozar; J F Suárez-Novo; M Castells-Esteve; P Fernández-Gonzalo; B De-Paula-Carranza; M Ferrer; F Guedea; G Sancho-Pardo; J Craven-Bartle; M J Ortiz-Gordillo; P Cabrera-Roldán; J I Rodríguez-Melcón; E Herrera-Ramos; C Rodríguez-Gallego; P C Lara
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-01-12       Impact factor: 5.554

3.  Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer.

Authors:  Ning Shao; JiuMing Li; Bin Xu; Yang Wang; XiaoJie Lu; NingHan Feng
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

4.  Combined haploinsufficiency and genetic control of the G2/M checkpoint in irradiated cells.

Authors:  Erik F Young; Lubomir B Smilenov; Howard B Lieberman; Eric J Hall
Journal:  Radiat Res       Date:  2012-05-18       Impact factor: 2.841

5.  Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.

Authors:  Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

6.  BRCA2 3'-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p.

Authors:  Nan Guo; Peng Qu; Hao Li; Liuli Liu; Hao Jin; Renqi Liu; Zhen Zhang; Xuan Zhang; Yingchun Li; Xiaobo Lu; Yuejiao Zhao
Journal:  Pharmgenomics Pers Med       Date:  2021-05-06

7.  A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.

Authors:  Josephine Kang; Alan D D'Andrea; David Kozono
Journal:  J Natl Cancer Inst       Date:  2012-04-13       Impact factor: 13.506

8.  Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis.

Authors:  Shang Xie; Xiao-Feng Shan; Kun Shang; Hui Xu; Jing He; Zhi-Gang Cai
Journal:  Sci Rep       Date:  2014-10-15       Impact factor: 4.379

9.  DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms.

Authors:  Ana P Azevedo; Susana N Silva; João P De Lima; Alice Reichert; Fernando Lima; Esmeraldina Júnior; José Rueff
Journal:  Oncol Lett       Date:  2017-04-21       Impact factor: 2.967

Review 10.  DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.

Authors:  Ruixue Huang; Ping-Kun Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.